The evidence discussed in this study suggests that a small, blood brain barrier-permeable molecule that acts as a BDNF mimetic, could counteract the harmful effects of Aβ and concomitantly induce re-myelination in AD. The gene discussed is BDNF; the disease is Alzheimer disease.